{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:44:28Z","timestamp":1792806268478,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Surgery remains the primary treatment for pancreatic ductal adenocarcinoma (PDAC), which has remarkably high morbidity and mortality rates. However, recurrence is prevalent after resection. The effectiveness of circulating tumor DNA (ctDNA) in recurrence prediction has been demonstrated, and methylation has advantages over traditional biomarkers in terms of early-stage specificity. These advances indicate the need for a ctDNA-based methylation marker for PDAC prognosis, which would be valuable in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>MIR129-2 promoter methylation markers were identified via a combination of differential methylation, differential expression, gene set enrichment analysis and survival analysis using TCGA data. A qPCR-based assay was developed to quantify MIR129-2 methylation in plasma samples with as little as 0.05% tumor DNA. Its performance in PDAC diagnosis and progression risk evaluation was evaluated using tissue (314 tumor vs. 306 normal) and plasma (187 PDAC vs. 59 normal) samples from two independent retrospective cohorts. A longitudinal cohort study (114 patients) was conducted to assess its performance in determining PDAC prognosis. Both before surgery and after surgery, plasma samples were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      MIR129-2 methylation showed excellent performance in differentiating PDAC and normal tissues, with a sensitivity of 97.77% and a specificity of 98.71%. For the plasma samples, it had a high sensitivity of 87.20% and a specificity of 98.30%. Survival analysis revealed its ability to predict postoperative survival outcomes even in CA19-9-negative patients (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Postoperative measurement of ctDNA-based MIR129-2 methylation can be used to predict PDAC recurrence risk, offering a cost-effective assay to facilitate the postoperative management of PDAC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003449","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:01:16Z","timestamp":1758132076000},"page":"433-442","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Supervising the recurrence of pancreatic ductal adenocarcinoma using CtDNA-based MIR129-2 methylation detection"],"prefix":"10.1097","volume":"112","author":[{"given":"Wen-Quan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-Chen","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yong","family":"Wang","sequence":"additional","affiliation":[{"name":"Smartquerier Gene Technology (Shanghai) Co., Ltd. Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qi","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yi","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[{"name":"Smartquerier Gene Technology (Shanghai) Co., Ltd. Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bao","family":"Pan","sequence":"additional","affiliation":[{"name":"Smartquerier Gene Technology (Shanghai) Co., Ltd. Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Institute for Digital Health, International Human Phenome Institutes (Shanghai), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Bo","family":"Cao","sequence":"additional","affiliation":[{"name":"Smartquerier Gene Technology (Shanghai) Co., Ltd. Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hui","family":"Ding","sequence":"additional","affiliation":[{"name":"Institute for Digital Health, International Human Phenome Institutes (Shanghai), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-An","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Xiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-9860","authenticated-orcid":false,"given":"Xiang-Tao","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Artifical Intelligence and Big Data, Guangzhou Vocational University of Science and Technology, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"R1-20260518","first-page":"100082","article-title":"Transparency in the Reporting of Artificial Intelligence \u2013 the TITAN Guideline","volume":"10","author":"Riaz","year":"2025","journal-title":"Premier J Sci"},{"key":"R2-20260518","doi-asserted-by":"crossref","first-page":"2008\u201320","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"R3-20260518","doi-asserted-by":"crossref","first-page":"11\u201326","DOI":"10.1038\/s41571-018-0112-1","article-title":"Optimizing the outcomes of pancreatic cancer surgery","volume":"16","author":"Strobel","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"272\u201386","DOI":"10.1038\/s43018-022-00349-2","article-title":"Translational advances in pancreatic ductal adenocarcinoma therapy","volume":"3","author":"Hosein","year":"2022","journal-title":"Nat Cancer"},{"key":"R5-20260518","first-page":"7\u201333","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R6-20260518","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"R7-20260518","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-021-01309-7","article-title":"Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication","volume":"20","author":"Hou","year":"2021","journal-title":"Mol Cancer"},{"key":"R8-20260518","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J Hematol Oncol"},{"key":"R9-20260518","doi-asserted-by":"crossref","first-page":"1148\u201355","DOI":"10.1111\/cas.13972","article-title":"Clinical utility of circulating tumor DNA for colorectal cancer","volume":"110","author":"Osumi","year":"2019","journal-title":"Cancer Sci"},{"key":"R10-20260518","doi-asserted-by":"crossref","first-page":"177\u201382","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"R11-20260518","doi-asserted-by":"crossref","first-page":"985\u201390","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nature Med"},{"key":"R12-20260518","doi-asserted-by":"crossref","first-page":"777\u201386","DOI":"10.1016\/S0140-6736(18)31268-6","article-title":"Principles of DNA methylation and their implications for biology and medicine","volume":"392","author":"Dor","year":"2018","journal-title":"Lancet"},{"key":"R13-20260518","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.1002\/mco2.766","article-title":"Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges","volume":"5","author":"Li","year":"2024","journal-title":"MedComm"},{"key":"R14-20260518","first-page":"745\u201359","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann Oncol"},{"key":"R15-20260518","doi-asserted-by":"crossref","first-page":"eaaw0726","DOI":"10.1126\/science.aaw0726","article-title":"RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues","volume":"364","author":"Yizhak","year":"2019","journal-title":"Science"},{"key":"R16-20260518","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1741-7015-9-133","article-title":"Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer","volume":"9","author":"Warren","year":"2011","journal-title":"BMC Med"},{"key":"R17-20260518","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s12916-022-02647-z","article-title":"Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA","volume":"20","author":"Wu","year":"2022","journal-title":"BMC Med"},{"key":"R18-20260518","doi-asserted-by":"crossref","first-page":"1394\u2013403","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov"},{"key":"R19-20260518","first-page":"447\u201372","article-title":"Methylation-Specific PCR","volume":"1708","author":"Ramalho-Carvalho","year":"2018","journal-title":"Methods Mol Biol"},{"key":"R20-20260518","doi-asserted-by":"crossref","first-page":"eaaw3616","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"key":"R21-20260518","doi-asserted-by":"crossref","first-page":"2968\u201386","DOI":"10.1158\/2159-8290.CD-21-0634","article-title":"Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease","volume":"11","author":"Moding","year":"2021","journal-title":"Cancer Discov"},{"key":"R22-20260518","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/genes14051075","article-title":"Crosstalk between miRNAs and DNA methylation in cancer","volume":"14","author":"Saviana","year":"2023","journal-title":"Genes (Basel)"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:18:12Z","timestamp":1779110292000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003449","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"2025-03-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}